No CrossRef data available.
Article contents
Antipsychotic drugs in pregnancy
Published online by Cambridge University Press: 23 March 2020
Abstract
Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background
There has been significant increase in prescription of antipsychotic medication in the community for females in childbearing age the problem is we do not have clear guidelines because we do not have a control group.
Objectives
To evaluate maternal psychiatric, medical and perinatal outcomes associated with antipsychotic drugs in pregnancy.
Aim
To use wisdom when the risk is minimal for both mother and child.
Method
We study 3 pregnant women, one with a 6 years old, one with a 2 years old child and one still pregnant. We measure their blood sugar, blood pressure, fetal heart, movement, ultrasound using first generation antipsychotic (FGA).
Results
Patient became less psychotic then back to normal and fetal development is normal till now, no diabetes mellitus or hypertension, no malformation or abortion.
Conclusion
It is still too early to reach a clear and absolute use of safe antipsychotic drugs in pregnancy. A large sample is needed for a study and a control should be needed.
Disclosure of interest
The author has not supplied his/her declaration of competing interest.
- Type
- e-Poster viewing: Emergency psychiatry
- Information
- European Psychiatry , Volume 41 , Issue S1: Abstract of the 25th European Congress of Psychiatry , April 2017 , pp. S562
- Copyright
- Copyright © European Psychiatric Association 2017
You have
Access
Comments
No Comments have been published for this article.